Upload Avatar (500 x 500)
Yicheng Mao
maoyc@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Pharmaceutical Sciences
  • 2002/09-2006/07: Bachelor in Biotechnology, East China University of Science and Technology
  • 2007/09-2012/12: Ph.D. in Pharmacy, Ohio State University
  • 2013/04-2017/12: Lecturer, School of Pharmacy, Fudan University
  • 2017/12-Present: Associate Professor, School of Pharmacy, Fudan University
  • Shanghai Pujiang Talent (2014)
  • Shanghai Morning Light Scholar (2014)
  • Shanghai Youth Science and Technology Star (A category) (2019)
  • Shanghai Pharmaceutical Science and Technology Award (Basic Research Category) Second Prize (2017)
  • Fudan University School of Pharmacy Dechuan Teaching Award (2017)
  • Second Prize in National Young Teachers' Teaching Competition in Pharmacy (2017)
  • Second Prize in the Third National Young Teachers' Basic Skills Competition (English Group) (2018)
  • Fudan University Shanghai Medical College Excellent Teacher Award (2018)
  • Fudan University Hong Kong and Macao Outstanding Teaching Award (2018)
  • Third Weiai Weide Medical College 'Outstanding Educator' (2019)
  • Fudan University Advanced Individual in Employment Work (2019)
  • Fudan University School of Pharmacy 'My Favorite Teacher' (2018, 2019, 2021)
Design and molecular pharmacological mechanisms of novel compounds of gas signal molecules
Activity detection and pharmacological mechanism research of natural drugs
Discovery of new drug targets and molecular pharmacological mechanisms
  • S-propargyl-cysteine Ameliorates Peripheral Nerve Injury through Microvascular Reconstruction, H Xi, C Wang, Q Li, Q Ye, Y Zhu, Y Mao, 2023
  • S-propargyl-cysteine presents concanavalin A-induced immunological liver injury in mice, B Ma, Y Mao, L Chang, T Dai, X Xin, F Ma, Z Wang, Z Shen, Q Mei, Y Zhu, 2022
  • Liriogerphines A-D, a Class of Sesquiterpene-Alkaloid Hybrids from the Rare Chinese Tulip Tree Plant, Y He, Q Li, Y Wu, C Jiang, Q Zhou, Z Jin, W Chen, Y Mao, J Hu, J Xiong, 2022
  • Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models, W Hu, M Li, W Sun, Q Li, H Xi, Y Qiu, R Wang, Q Ding, Z Wang, Y Yu, He Lei, Y Mao, Y-Z Zhu, 2022
  • Advances in the Protective Mechanism of NO, H2S, and H2 in Myocardial Ischemic Injury, W Wang, T Ge, X Chen, Y Mao, Y-Z Zhu, 2020
  • ZYZ-803, a novel hydrogen sulfide-nitric oxide conjugated donor, promotes angiogenesis via cross-talk between STAT3 and CaMKII, Y Xiong, L Chang, B Tran, T Dai, R Zhong, Y Mao, Y-Z Zhu, 2020
  • A Novel Liposomal S-Propargyl-Cysteine: A Sustained Release of Hydrogen Sulfide Reducing Myocardial Fibrosis via TGF-beta 1/Smad Pathway, B Tran, Y Yu, L Chang, B Tan, W Jia, Y Xiong, T Dai, R Zhong, W Zhang, M Van, P Rose, Z Wang, Y Mao, Y-Z Zhu, 2019
  • ZYZ-803 Mitigates Endoplasmic Reticulum Stress-Related Necroptosis after Acute Myocardial Infarction through Downregulating the RIP3-CaMKII Signaling Pathway, L Chang, Z Wang, F Ma, B Tran, R Zhong, Y Xiong, T Dai, J Wu, X Xin, W Guo, Y Xie, Y Mao, Y-Z Zhu, 2019
  • Novel H2S-NO hybrid molecule (ZYZ-803) promoted synergistic effects against heart failure, D Wu, Q Hu, Y Xiong, D Zhu, Y Mao, Y-Z Zhu, 2018
Gas Signal Molecules Novel Compounds Molecular Pharmacology Design Mechanisms Natural Drugs Activity Detection Pharmacological Research Drug Targets Discovery

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.